CASC2 sensitized glioma cells to TMZ and amplified the TMZ-induced suppression of cell proliferation by upregulating PTEN protein expression and downregulating phosphorylated AKT through miR-181a (156). This evidence concerns the gene CASC2 and central nervous system cancer.